Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Tsoi, Bernice
Masucci, Lisa
Campbell, Kaitryn
Drummond, Michael
O’Reilly, Daria
and
Goeree, Ron
2013.
Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 13,
Issue. 4,
p.
497.
Wonder, Michael
Backhouse, Martin E.
and
Hornby, Edward
2013.
Early Scientific Advice Obtained Simultaneously from Regulators and Payers: Findings from a Pilot Study in Australia.
Value in Health,
Vol. 16,
Issue. 6,
p.
1067.
Henshall, Chris
Sansom, Lloyd
Eichler, Hans-Georg
Lemgruber, Alexandre
Longson, Carole
O’Rourke, Brian
and
Tunis, Sean
2014.
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?.
Therapeutic Innovation & Regulatory Science,
Vol. 48,
Issue. 3,
p.
341.
Wonder, Michael
2014.
What can be gained from increased early-stage interaction between regulators, payers and the pharmaceutical industry?.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 14,
Issue. 4,
p.
465.
Armataki, Eleni
Karampli, Eleftheria
Kyriopoulos, John
and
Pavi, Elpida
2014.
HEALTH TECHNOLOGY ASSESSMENT OF MEDICINES IN GREECE: PHARMACEUTICAL INDUSTRY EXECUTIVES' VIEWS.
International Journal of Technology Assessment in Health Care,
Vol. 30,
Issue. 2,
p.
226.
van Hasselt, JGC
Gupta, A
Hussein, Z
Beijnen, JH
Schellens, JHM
and
Huitema, ADR
2015.
Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration‐Resistant Prostate Cancer Treatment With Eribulin.
CPT: Pharmacometrics & Systems Pharmacology,
Vol. 4,
Issue. 7,
p.
374.
Cressman, Sonya
Browman, George P.
Hoch, Jeffrey S.
Kovacic, Laurel
and
Peacock, Stuart J.
2015.
A Time-Trend Economic Analysis of Cancer Drug Trials.
The Oncologist,
Vol. 20,
Issue. 7,
p.
729.
Cook, Sarah F.
and
Bies, Robert R.
2016.
Disease Progression Modeling: Key Concepts and Recent Developments.
Current Pharmacology Reports,
Vol. 2,
Issue. 5,
p.
221.
Drummond, Michael
Tarricone, Rosanna
and
Torbica, Aleksandra
2016.
Incentivizing research into the effectiveness of medical devices.
The European Journal of Health Economics,
Vol. 17,
Issue. 9,
p.
1055.
Kano, Shingo
2016.
Interaction analysis between innovation and regulation: The concept of Regulatory Science as a Process (RaaP) and its applications.
p.
1278.
Zannad, Faiez
Alonso Garcia, Maria de los Angeles
Borer, Jeffrey S.
Stough, Wendy Gattis
Clutton-Brock, Thomas
Rosenberg, Yves
and
Packer, Milton
2017.
Role of Payers in the Development of Cardiovascular Therapeutics.
Journal of the American College of Cardiology,
Vol. 70,
Issue. 22,
p.
2822.
Dintsios, Charalabos-Markos
and
Schlenkrich, Sara
2018.
INDUSTRY'S EXPERIENCES WITH THE SCIENTIFIC ADVICE OFFERED BY THE FEDERAL JOINT COMMITTEE WITHIN THE EARLY BENEFIT ASSESSMENT OF PHARMACEUTICALS IN GERMANY.
International Journal of Technology Assessment in Health Care,
Vol. 34,
Issue. 2,
p.
196.
Beck, ACC
Retèl, VP
Bhairosing, PA
van den Brekel, MWM
and
van Harten, WH
2019.
Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review.
Health Policy,
Vol. 123,
Issue. 12,
p.
1185.
Ofori-Asenso, Richard
Hallgreen, Christine E.
and
De Bruin, Marie Louise
2020.
Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges.
Frontiers in Medicine,
Vol. 7,
Issue. ,
Wang, Ting
McAuslane, Neil
Gardarsdottir, Helga
Goettsch, Wim G.
and
Leufkens, Hubert G.M.
2022.
Building HTA insights into the drug development plan: Current approaches to seeking early scientific advice from HTA agencies.
Drug Discovery Today,
Vol. 27,
Issue. 1,
p.
347.
Ramos, Maíra Catharina
Oliveira, Margarete Martins de
Andrade, Aurélio Matos de
Silva, Erica Tatiane da
and
Elias, Flávia Tavares Silva
2023.
Interações entre regulação sanitária e Avaliação de Tecnologias em Saúde para cobertura em sistemas de saúde e a integralidade do cuidado.
Saúde e Sociedade,
Vol. 32,
Issue. suppl 1,
Ramos, Maíra Catharina
Oliveira, Margarete Martins de
Andrade, Aurélio Matos de
Silva, Erica Tatiane da
and
Elias, Flávia Tavares Silva
2023.
Interactions between health regulation and Health Technology Assessment for coverage in health systems and comprehensive care.
Saúde e Sociedade,
Vol. 32,
Issue. suppl 1,